Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)

Clinical trial NCT00661492 · COMPLETED

Trial details

NCT number: NCT00661492
Sponsor: US Oncology Research
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Androgen-independent Prostate Cancer

Start date: 2008-05-01
Primary completion: 2011-03-01
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.